• Home
  • Events
  • Myelodysplastic syndromes and bone marrow failures: diagnostic and therapeutic advances - Monday Lunch Live
Back to all events
27 May 2019
  • Victorian Comprehensive Cancer Centre
1-2PM

Myelodysplastic syndromes and bone marrow failures: diagnostic and therapeutic advances - Monday Lunch Live

We invite you to hear Dr Austin Kulasekararaj, Consultant Haematologist from King’s College Hospital who works within the myeloid, allogeneic transplant and bone marrow failure services.

Dr Kulasekararaj's interests include understanding biological pathways and ineffective erythropoiesis in low risk MDS and BMF. His presentation will cover therapeutic advances and promising new agents in advance phase 2 and phase 3 trials.

Dr Austin Kulasekararaj

Dr Kulasekararaj leads the King’s National PNH service with his special interest in bone marrow failure syndromes - aplastic anaemia, PNH and myelodysplastic syndrome. His research interest is in molecular pathogenesis of myelodysplastic syndromes (MDS), especially the role of TP53 and other somatic mutations and he will be presenting on AML and MDS. 

Dr Kulasekararaj is visiting Melbourne as an Expert-In-Residence of Melbourne Genomics Health Alliance.

1a RGB 01Melbourne Genomics MASTER wordmark

Can't attend in person? Register for Webinar